Cancer Incidence and Mortality among Non-Hispanic Blacks, New York County (Manhattan), 2005-2009
Source: New York State Cancer Registry
| Site of Cancer | Incidence | Mortality | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Males | Females | Males | Females | |||||||||
| Average Annual Cases | Rate per 100,000 Males | 95% CI (+/-) | Average Annual Cases | Rate per 100,000 Females | 95% CI (+/-) | Average Annual Deaths | Rate per 100,000 Males | 95% CI (+/-) | Average Annual Deaths | Rate per 100,000 Females | 95% CI (+/-) | |
| All Invasive Malignant Tumors | 685.0 | 691.0 | 23.5 | 669.6 | 454.6 | 15.8 | 277.6 | 299.4 | 16.0 | 314.8 | 203.0 | 10.3 |
| Oral cavity and pharynx | 20.0 | 19.8 | 3.9 | 9.6 | 6.8 | 2.0 | 6.2 | 6.6 | 2.4 | 3.6 | 2.4 | 1.1 |
| Esophagus | 10.2 | 10.5 | 2.9 | 6.6 | 4.2 | 1.5 | 7.4 | 8.0 | 2.6 | 6.2 | 4.0 | 1.4 |
| Stomach | 16.4 | 17.4 | 3.8 | 16.6 | 10.4 | 2.3 | 10.0 | 11.1 | 3.1 | 10.4 | 6.2 | 1.7 |
| Colorectal | 60.0 | 62.2 | 7.2 | 76.8 | 49.6 | 5.1 | 25.2 | 27.7 | 4.9 | 36.8 | 22.6 | 3.3 |
| Colon excluding rectum | 42.4 | 45.0 | 6.2 | 57.6 | 37.1 | 4.4 | 20.2 | 22.3 | 4.4 | 32.4 | 19.9 | 3.1 |
| Rectum & rectosigmoid | 17.6 | 17.2 | 3.6 | 19.2 | 12.4 | 2.5 | 5.0 | 5.4 | 2.1 | 4.4 | 2.8 | 1.2 |
| Liver / intrahepatic bile duct | 34.4 | 32.5 | 4.9 | 9.4 | 6.2 | 1.8 | 21.6 | 20.7 | 4.0 | 7.0 | 4.7 | 1.6 |
| Pancreas | 17.2 | 17.5 | 3.8 | 28.0 | 17.5 | 3.0 | 15.4 | 16.2 | 3.7 | 24.0 | 14.5 | 2.6 |
| Larynx | 10.8 | 10.6 | 2.9 | 4.6 | 3.0 | 1.2 | 6.0 | 6.5 | 2.4 | 1.2 | 0.8 | 0.7 |
| Lung and bronchus | 99.6 | 102.8 | 9.2 | 84.0 | 54.8 | 5.3 | 77.0 | 80.4 | 8.2 | 65.8 | 42.5 | 4.7 |
| Melanoma of the skin | 2.0 | 2.1 | 1.4 | 2.2 | 1.6 | 1.0 | 0.8 | 0.8 | 0.8 | 0.6 | 0.5 | 0.6 |
| Female breast | 195.0 | 137.8 | 8.9 | 55.6 | 37.0 | 4.5 | ||||||
| Cervix uteri | 16.8 | 12.0 | 2.6 | 8.6 | 5.9 | 1.8 | ||||||
| Corpus uterus and NOS | 42.0 | 27.4 | 3.8 | 17.2 | 10.9 | 2.3 | ||||||
| Ovary | 15.8 | 10.5 | 2.4 | 13.6 | 9.1 | 2.2 | ||||||
| Prostate | 241.6 | 241.3 | 13.8 | 46.0 | 56.3 | 7.4 | ||||||
| Testis | 2.2 | 1.9 | 1.1 | 0.2 | 0.2 | 0.3 | ||||||
| Urinary bladder (incl. in situ) | 22.0 | 23.2 | 4.4 | 9.4 | 5.7 | 1.7 | 6.2 | 7.1 | 2.6 | 3.4 | 1.9 | 0.9 |
| Kidney and renal pelvis | 21.0 | 20.7 | 4.0 | 15.8 | 10.7 | 2.4 | 5.8 | 5.7 | 2.1 | 3.8 | 2.3 | 1.1 |
| Brain and other nervous system | 3.2 | 3.3 | 1.6 | 5.8 | 4.2 | 1.6 | 2.8 | 2.9 | 1.5 | 3.2 | 2.2 | 1.1 |
| Thyroid | 3.4 | 3.1 | 1.5 | 14.2 | 10.7 | 2.6 | 0.4 | 0.4 | 0.5 | 1.0 | 0.7 | 0.6 |
| Hodgkin lymphoma | 6.4 | 5.7 | 2.0 | 3.2 | 2.4 | 1.2 | 0.4 | 0.4 | 0.6 | 0.4 | 0.3 | 0.4 |
| Non-Hodgkin lymphomas | 22.4 | 21.5 | 4.0 | 22.6 | 16.1 | 3.0 | 6.2 | 6.2 | 2.2 | 7.2 | 5.1 | 1.7 |
| Multiple myeloma | 16.4 | 17.1 | 3.8 | 19.0 | 12.1 | 2.5 | 6.0 | 6.3 | 2.3 | 8.0 | 5.1 | 1.6 |
| Leukemias | 13.0 | 13.8 | 3.4 | 11.4 | 8.4 | 2.3 | 8.6 | 9.6 | 2.9 | 6.6 | 4.4 | 1.5 |
Notes
- Incidence data are provisional, November 2011.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.
